spacer
home > pmps > summer 2008 > special dispensation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Special Dispensation

Pressure is increasing on today’s pharmaceutical industry to implement more reliable and consistent safeguards against mistakes in dispensing medication, whether from contamination, mixing up drugs or inappropriate dosing. As a result, pharmaceutical companies are turning to non-destructive testing (NDT) techniques for product and packaging inspection.

A number of these techniques have already been adopted, including the use of optical, infra-red, ultrasound, vacuum decay and x-ray inspection methods. Traditionally, these have primarily been used for batch control through various batch sampling and inspection strategies. However, there is increasing demand for in-line inspection of all products, particularly where they have high commercial value or involve high dosage levels.

Applications for in-line NDT of products are as varied as the products themselves. Typical inspection scenarios may entail: checking fill levels in bottles and tubs of drugs, in liquid, powder, and even tablet forms; checking for missing tablets in blister packs; detecting contaminants (such as metal or glass) in dressings; and checking for correctly assembled devices.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Martin Allen graduated from Nottingham University with an Honours Degree in Geology in 1989 and gained a Doctorate in Engineering in 1993, specialising in image processing and analysis. After two years of developing an advanced document imaging system, Martin joined the software department of OIS Engineering in 1996. Some 11 years later, OIS has become Shaw Inspection Systems, and Martin has become a leading expert in both digital radiography (DR), and computed tomography (CT). He now heads the software department and is responsible for current research and development into both DR and CT.
spacer
Martin Allen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Entry now open for the PPMA Group Industry Awards 2019

The 2019 PPMA Group Industry Awards will be held at the National Conference Centre (NEC), Birmingham, on the evening of the first day of the PPMA Total Show 2019 – Tuesday, 1 October 2019. 
More info >>

White Papers

Case Study: Cmed’s Mobile Data Management Solution

Cmed Clinical Services

The trial presented to Cmed was a randomized, double blinded, placebo and active controlled study to evaluate the cardiac safety of multiple doses of [study drug] in health volunteers. The pharmaceutical company, who were into the second year of development of a potential blockbuster compound for the treatment of chronic myelogenous leukaemia (CML), were requested by the FDA to design a trial to provide information on the cardiac safety of different dose levels of the study drug in healthy adult volunteers. The primary objective of the study was specifically to find the maximum tolerated dose before QTc levels became unsafe. All development of the compound was put on hold until the results of this study were submitted to the FDA and approval granted for the compound to progress into full development.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement